Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

por Tanabe, Hiroki, Yoshino, Keiichi, Ando, Katsuyoshi, Nomura, Yoshiki, Ohta, Katsuhisa, Satoh, Kiichi, Ichiishi, Eiichiro, Ishizuka, Akiei, Otake, Takaaki, Kohgo, Yutaka, Fujiya, Mikihiro, Okumura, Toshikatsu
Publicado 2018